Effect of SAMe-TT₂R₂ score and genetic polymorphism on the quality of anticoagulation control in Qatari patients treated with warfarin حسب Hazem Elewa (3592601)

Potential Therapeutic Effects of Sodium Glucose-linked Cotransporter 2 Inhibitors in Stroke حسب Fatima Alzahra Al Hamed (17115562)

مؤلفون آخرون: "…Hazem Elewa (3592601)…"

Warfarin dosing strategies evolution and its progress in the era of precision medicine, a narrative review حسب Amr Mohamed Fahmi (14151513)

مؤلفون آخرون: "…Hazem Elewa (3592601)…"

The Dilemma of Peri-Procedural Warfarin Management: A Narrative Review حسب Islam Eljilany (14151588)

مؤلفون آخرون:

Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management حسب Islam Eljilany (14151588)

مؤلفون آخرون: "…Hazem Elewa (3592601)…"

Genetic Polymorphism Effect on Warfarin–Rifampin Interaction: A Case Report and Review of Literature حسب Muhammad Salem (8979428)

مؤلفون آخرون:

A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country حسب Nancy Zaghloul (14147865)

مؤلفون آخرون:

Anticoagulation clinic drive-up service during COVID-19 pandemic in Qatar حسب Eman Alhmoud (13955766)

مؤلفون آخرون:

Evaluating the appropriateness and the factors associated with sodium-glucose co-transporter 2 inhibitors prescribing in a Middle Eastern country: a cross-sectional study حسب Nancy Zaghloul (14147865)

مؤلفون آخرون:

Drive‐up INR testing and phone‐based consultations service during COVID‐19 pandemic in a pharmacist‐lead anticoagulation clinic in Qatar: Monitoring, clinical, resource utilization... حسب Eman N. Alhmoud (14778706)

مؤلفون آخرون:

Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-a... حسب Mohamed Nabil Elshafei (9960500)

مؤلفون آخرون:

Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey حسب Islam Eljilany (14151588)

مؤلفون آخرون:

Bridging vs Non-Bridging with Warfarin Peri-Procedural Management: Cost and Cost-Effectiveness Analyses حسب Islam Eljilany (14151588)

مؤلفون آخرون: "…Hazem Elewa (3592601)…"

Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma حسب Nabil E. Omar (9545756)

مؤلفون آخرون: "…Hazem Elewa (3592601)…"

Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data حسب Majdoleen Alalawneh (13961580)

مؤلفون آخرون:

Accuracy of an internationally validated genetic-guided warfarin dosing algorithm compared to a clinical algorithm in an Arab population حسب Amr M. Fahmi (21632909)

مؤلفون آخرون:

Pharmacokinetics of single‐dose rivaroxaban under fed state in obese vs. non‐obese subjects: An open‐label controlled clinical trial (RIVOBESE‐PK) حسب Majdoleen Alalawneh (13961580)

مؤلفون آخرون:

Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study حسب Islam Eljilany (14151588)

مؤلفون آخرون:

Clinical versus fixed warfarin dosing and the impact on quality of anticoagulation (The ClinFix trial) حسب Amr M. Fahmi (21632909)

مؤلفون آخرون:

QPGx‐CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies حسب Rania Abdel‐latif (14778559)

مؤلفون آخرون: